VCP and cancer: Recent genome-wide shRNA screens identified various components of PQC, such as proteasomal subunits and VCP, as essential genes in cancer cells.19,20 Therefore, VCP inhibitors may serve as novel cancer therapeutics that exploit unique vulnerabilities or dependencies of cancer cells.